[8-K] Healthpeak Properties, Inc. Reports Material Event

Rhea-AI Filing Summary

On 22 July 2025, DXC Technology Company (DXC) held its 2025 Annual Meeting of Stockholders and disclosed the certified voting results in this Form 8-K (Item 5.07).

• Board elections: All ten director nominees—headed by David A. Barnes and Raul J. Fernandez—were elected to serve until the 2026 meeting. Support levels were strong, with the lowest "For" tally at 136.2 million votes and the highest at 142.6 million; broker non-votes totaled 18.5 million for each nominee.
• Auditor ratification: Deloitte & Touche LLP was re-appointed as independent auditor for FY 2026, receiving 151.7 million "For" votes versus 10.2 million "Against" and 0.4 million abstentions.
• Say-on-pay: Shareholders approved the advisory vote on named-executive compensation with 135.6 million "For" votes (approx. 93% of votes cast), 7.5 million "Against," and 0.7 million abstentions.

No other matters were brought before shareholders, and there were no disclosures regarding financial performance, strategic transactions, or guidance. The filing is primarily procedural, confirming continued shareholder support for DXC’s leadership, compensation practices, and external auditor.

Insights

Corporate Governance Analyst

TL;DR: Routine annual-meeting results; strong shareholder support, no material surprises, neutral market impact.

The 8-K reports standard governance outcomes: all nominees elected, auditor re-ratified, and say-on-pay passed comfortably. Support percentages exceed typical S&P 500 medians, suggesting shareholder alignment with current strategy and leadership. However, these results were widely anticipated and do not alter DXC’s financial outlook or risk profile. No new initiatives, capital actions, or operational updates were provided. Accordingly, the filing is classified as not impactful for valuation or near-term trading but does confirm governance stability.

0000765880false00007658802025-07-242025-07-240000765880dei:FormerAddressMember2025-07-242025-07-24

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

July 24, 2025

Date of Report (Date of earliest event reported)

Healthpeak Properties, Inc.

(Exact name of registrant as specified in its charter)

Maryland

001-08895

33-0091377

(State or other jurisdiction of incorporation)

(Commission File Number)

(IRS Employer Identification No.)

4600 South Syracuse Street, Suite 500

Denver, CO 80237

(Address of principal executive offices) (Zip Code)

(720) 428-5050

(Registrant’s telephone number, including area code)

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class			Trading Symbol(s)			Name of each exchange on which registered
Common Stock, $1.00 par value			DOC			New York Stock Exchange

 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02                                           Results of Operations and Financial Condition.

On July 24, 2025, Healthpeak Properties, Inc., a Maryland corporation (“Healthpeak”), issued a press release setting forth its financial results for the three and six months ended June 30, 2025. The press release refers to the Discussion and Reconciliation of Non-GAAP Financial Measures, which is available in the Investor Relations section of Healthpeak’s website, free of charge, at http://ir.healthpeak.com/quarterly-results. The press release and Discussion and Reconciliation of Non-GAAP Financial Measures are furnished herewith as Exhibits 99.1 and 99.3, respectively, and are incorporated by reference herein.

The information set forth in this Item 2.02 of this Current Report on Form 8-K and the related information in Exhibits 99.1 and 99.3 attached hereto are being furnished herewith, and shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and shall not be incorporated by reference in any filing with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except as shall be expressly set forth by specific reference therein.

Item 7.01                                           Regulation FD Disclosure.

A supplemental report containing financial results and related information of Healthpeak for the three and six months ended June 30, 2025 is furnished as Exhibit 99.2 hereto and incorporated by reference herein. The supplemental report is also available in the Investor Relations section of Healthpeak’s website, free of charge, at http://ir.healthpeak.com/quarterly-results.

The information set forth in this Item 7.01 of this Current Report on Form 8-K and the related information in Exhibit 99.2 attached hereto is being furnished herewith, and shall not be deemed filed for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that section, and shall not be incorporated by reference in any filing with the Securities and Exchange Commission under the Securities Act or the Exchange Act, except as shall be expressly set forth by specific reference therein.

Item 9.01                                           Financial Statements and Exhibits.

(d)                                 Exhibits.  The following exhibits are being furnished herewith:

No.						Description
99.1						Press Release dated July 24, 2025.
99.2						June 30, 2025, Supplemental Report.
99.3						June 30, 2025, Discussion and Reconciliation of Non-GAAP Financial Measures.
104						Cover Page Interactive Data File (embedded within the inline XBRL document and contained in Exhibit 101).

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: July 24, 2025
			Healthpeak Properties, Inc.
			By:			/s/ Kelvin O. Moses
						Kelvin O. Moses
						Chief Financial Officer

3

FAQ

What decisions were made at DXC's 2025 Annual Meeting?

Shareholders elected all ten directors, ratified Deloitte & Touche as auditor for FY 2026, and approved executive compensation on an advisory basis.

Did DXC shareholders approve the say-on-pay proposal?

Yes. Approximately 135.6 million votes were cast in favor, with 7.5 million against and 0.7 million abstaining.

Was Deloitte & Touche re-appointed as DXC's auditor?

Yes. The firm received 151.7 million votes in favor versus 10.2 million against.

Were there any other matters voted on at the DXC 2025 Annual Meeting?

No. Only the director elections, auditor ratification, and advisory say-on-pay were submitted to shareholders.

Does the 8-K contain financial or strategic updates for DXC (NYSE: DXC)?

No. The filing is limited to shareholder voting results and offers no earnings, guidance, or transaction details.